Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 21, 2022
If economists are the ‘dismal scientists’ always harping on about limited resources, evaluators are often considered the ‘pessimist scientists’ who only see the half-empty glass, rather than the half-full one. The end of the year is, however, a perfect time to break with that tradition. It is a time...
Blog Post
December 19, 2022
About 63 percent of Nigeria’s population is multidimensionally poor, and Nigeria’s debt service-to-revenue ratio at the federal government level reached 83 percent during the first eight months of 2022. In short, the country is facing significant fiscal-macroeconomic challenges, with implications fo...
CGD NOTES
December 19, 2022
The next administration in Nigeria will face significant fiscal-macroeconomic challenges. This note focuses on adopting a more integrated and comprehensive framework for the conduct of fiscal policy, with emphasis on improving domestic resource mobilization, enhancing expenditure efficiency, and exp...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 13, 2022
The case for multilateralism could not be clearer. It points to the many global problems that the world faces, which even the most powerful states cannot handle on their own. Containing global pandemics and mitigating climate change are tasks that require global cooperation. And yet, the future of t...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...